OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024
22 Février 2024 - 10:24PM
OrthoPediatrics Corp. (“OrthoPediatrics” or
the “Company”) (Nasdaq: KIDS), a company focused exclusively on
advancing the field of pediatric orthopedics, today announced that
the Company is scheduled to release its fourth quarter and full
year 2023 financial results on Wednesday, March 6, 2024, after the
market closes. OrthoPediatrics will host a conference call on
Thursday, March 7, 2024, at 8:00 a.m. ET to discuss the results.
Investors interested in listening to the
conference call may do so by accessing a live and archived webcast
of the event at www.orthopediatrics.com, on the Investors page in
the Events & Presentations section. The webcast will be
available for replay for at least 90 days after the event.
About OrthoPediatrics
Corp.Founded in 2006, OrthoPediatrics is an orthopedic
company focused exclusively on advancing the field of pediatric
orthopedics. As such it has developed the most comprehensive
product offering to the pediatric orthopedic market to improve the
lives of children with orthopedic conditions. OrthoPediatrics
currently markets 71 products that serve three of the largest
categories within the pediatric orthopedic market. This product
offering spans trauma and deformity, scoliosis, and sports
medicine/other procedures. OrthoPediatrics’ global sales
organization is focused exclusively on pediatric orthopedics and
distributes its products in the United States and over 71 countries
outside the United States. For more information, please visit
www.orthopediatrics.com.
Investor ContactPhilip Trip
TaylorGilmartin Groupphilip@gilmartinir.com 415-937-5406
OrthoPediatrics (NASDAQ:KIDS)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
OrthoPediatrics (NASDAQ:KIDS)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024